Reply to Harry Herr's Letter to the Editor re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61

Affiliations

¹ Department of Urology, Hospital Motol, Second Faculty of Medicine, Charles University, Prague, Czech Republic. Electronic address: marek.babjuk@lfmotol.cuni.cz.
² Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany.
³ Department of Pathology, Hôpital La Pitié-Salpétrière, UPMC, Paris, France.
⁴ Department of Urology, Fundació Puigvert, Universidad Autónoma de Barcelona, Barcelona, Spain.
⁵ AP-HP, Hôpital La Pitié-Salpétrière, Service d'Urologie, Paris, France; UPMC University Paris 06, GRC5, ONCOTYPE-Uro, Institut Universitaire de Cancérologie, Paris, France.
⁶ Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
⁷ Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
⁸ European Association of Urology Guidelines Office, Brussels, Belgium.
⁹ Department of Urology, Medical University of Graz, Graz, Austria.
¹⁰ Urology Clinic, Citta della Salute e della Scienza di Torino, University of Studies of Turin, Turin, Italy.
¹¹ Department of Urology, North Hampshire Hospital, Basingstoke, Hampshire.

Comment

Marko Babjuk et al. Eur Urol. 2017 Jun.

. 2017 Jun;71(6):e173-e174.

doi: 10.1016/j.eururo.2016.11.029. Epub 2016 Dec 7.

¹ Department of Urology, Hospital Motol, Second Faculty of Medicine, Charles University, Prague, Czech Republic. Electronic address: marek.babjuk@lfmotol.cuni.cz.
² Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany.
³ Department of Pathology, Hôpital La Pitié-Salpétrière, UPMC, Paris, France.
⁴ Department of Urology, Fundació Puigvert, Universidad Autónoma de Barcelona, Barcelona, Spain.
⁵ AP-HP, Hôpital La Pitié-Salpétrière, Service d'Urologie, Paris, France; UPMC University Paris 06, GRC5, ONCOTYPE-Uro, Institut Universitaire de Cancérologie, Paris, France.
⁶ Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
⁷ Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
⁸ European Association of Urology Guidelines Office, Brussels, Belgium.
⁹ Department of Urology, Medical University of Graz, Graz, Austria.
¹⁰ Urology Clinic, Citta della Salute e della Scienza di Torino, University of Studies of Turin, Turin, Italy.
¹¹ Department of Urology, North Hampshire Hospital, Basingstoke, Hampshire.

No abstract available

Comment on

EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, Hernández V, Kaasinen E, Palou J, Rouprêt M, van Rhijn BWG, Shariat SF, Soukup V, Sylvester RJ, Zigeuner R. Babjuk M, et al. Eur Urol. 2017 Mar;71(3):447-461. doi: 10.1016/j.eururo.2016.05.041. Epub 2016 Jun 17. Eur Urol. 2017. PMID: 27324428
Re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61.
Herr H. Herr H. Eur Urol. 2017 Jun;71(6):e171-e172. doi: 10.1016/j.eururo.2016.11.030. Epub 2016 Dec 12. Eur Urol. 2017. PMID: 27979427 No abstract available.